# Cherimoya Turmeric (Curcuma longa)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/cherimoya-turmeric
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-04
**Evidence Score:** 2 / 10
**Category:** Other
**Also Known As:** Curcuma longa, turmeric, Indian saffron, yellow ginger, haldi, kunyit, ukon, jiang huang

## Overview

Cherimoya Turmeric is a high-yielding cultivar of Curcuma longa selectively developed for elevated curcuminoid content, with some genotypes producing up to 5.02% curcuminoids by dry weight. Its primary bioactive compounds—curcumin, bisdemethoxycurcumin, and demethoxycurcumin—are studied for their inhibition of [NF-κB](/ingredients/condition/inflammation) signaling and COX-2 enzyme activity, though no clinical trials have evaluated this specific variety.

## Health Benefits

• No clinical health benefits documented - research dossier contains no human trials or clinical evidence
• Traditional culinary use as a spice and preservative in Indian and Southeast Asian cuisines
• High-yielding genotypes may contain up to 5.02% curcuminoids, though health effects not clinically studied
• Essential oils like beta-cymene noted for [antimicrobial](/ingredients/condition/immune-support) properties in laboratory settings only
• No evidence-based health claims can be made from available research

## Mechanism of Action

Curcuminoids in Curcuma longa cultivars like Cherimoya Turmeric inhibit nuclear factor kappa B (NF-κB) activation, suppressing downstream [pro-inflammatory cytokine](/ingredients/condition/inflammation)s such as TNF-α, IL-1β, and IL-6. Curcumin also downregulates cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) enzymes, reducing prostaglandin and leukotriene synthesis. Additionally, curcumin activates Nrf2/ARE pathways, upregulating endogenous [antioxidant](/ingredients/condition/antioxidant) enzymes including superoxide dismutase (SOD) and heme oxygenase-1 (HO-1).

## Clinical Summary

No clinical trials have been conducted specifically on the Cherimoya Turmeric cultivar, leaving its health effects in humans undocumented at this variety level. Broader research on Curcuma longa extracts standardized to curcuminoids has included randomized controlled trials with sample sizes ranging from 30 to over 200 participants, examining outcomes such as joint pain scores, [inflammatory](/ingredients/condition/inflammation) biomarkers, and metabolic parameters. Evidence quality across general turmeric research is considered moderate, frequently limited by curcumin's poor oral bioavailability (estimated at under 1% without bioavailability enhancers such as piperine). Conclusions from Curcuma longa research cannot be directly extrapolated to Cherimoya Turmeric without cultivar-specific pharmacokinetic and clinical data.

## Nutritional Profile

Cherimoya Turmeric (Curcuma longa) is primarily characterized by its bioactive curcuminoid content, with high-yielding genotypes containing up to 5.02% total curcuminoids (curcumin, demethoxycurcumin, and bisdemethoxycurcumin). Standard dried turmeric powder typically contains approximately 2-3% curcumin by weight. Macronutrient profile per 100g dried powder: carbohydrates ~65g (including ~13g dietary fiber), protein ~8g, fat ~10g (including small amounts of omega-3 and omega-6 fatty acids). Key micronutrients include manganese (~19.8mg, ~860% DV), iron (~41.4mg), potassium (~2525mg), vitamin C (~25.9mg), and magnesium (~193mg). Essential oils comprise approximately 3-7% of dry weight, with notable volatile compounds including beta-cymene, turmerone, ar-turmerone, and zingiberene contributing [antimicrobial](/ingredients/condition/immune-support) properties observed in laboratory settings. Bioavailability note: curcuminoids exhibit poor oral bioavailability (~1%) due to rapid [metabolism](/ingredients/condition/weight-management) and low absorption; co-administration with piperine (black pepper) can increase bioavailability by up to 2000%. The 'Cherimoya' designation likely refers to a specific cultivar or hybrid variant; curcuminoid concentration may differ from standard Curcuma longa, with the documented 5.02% curcuminoid yield suggesting selective breeding for higher bioactive compound output.

## Dosage & Preparation

No clinically studied dosage ranges are available in the research. No standardization details for curcumin content or recommended forms (extract, powder) are provided. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

High-dose curcuminoid supplementation (above 4–8 g/day) has been associated with gastrointestinal side effects including nausea, diarrhea, and abdominal discomfort in human trials. Curcumin inhibits CYP3A4 and P-glycoprotein pathways, potentially increasing plasma concentrations of drugs such as warfarin, tacrolimus, and certain statins, requiring caution in polypharmacy contexts. Curcuminoids may have additive effects with antiplatelet and anticoagulant medications, increasing bleeding risk. Pregnant individuals should avoid supplemental doses of curcuminoids beyond culinary amounts, as high doses may stimulate uterine contractions; individuals with gallbladder disease or bile duct obstruction should also exercise caution.

## Scientific Research

No clinical trials, RCTs, or meta-analyses were found in the research dossier for Cherimoya Turmeric or standard Curcuma longa. The available sources focus solely on botanical characteristics and agricultural cultivation rather than human health studies.

## Historical & Cultural Context

Turmeric rhizomes have long been used as a spice in Indian and Southeast Asian cuisines for their color, flavor, and preservative qualities. Specific historical medicinal uses in traditional systems are not detailed in the available research.

## Synergistic Combinations

Insufficient research to recommend synergistic ingredients

## Frequently Asked Questions

### What makes Cherimoya Turmeric different from regular turmeric?

Cherimoya Turmeric is a selectively bred cultivar of Curcuma longa developed to produce exceptionally high curcuminoid concentrations, with some genotypes yielding up to 5.02% curcuminoids by dry weight compared to the 2–3% typical of commercial turmeric. This elevated curcuminoid profile makes it of interest for nutraceutical and food-industry applications. However, no published studies have compared its bioavailability or clinical efficacy directly against standard commercial turmeric varieties.

### Are there any clinical trials on Cherimoya Turmeric?

As of current available literature, no human clinical trials have been conducted specifically on the Cherimoya Turmeric cultivar. Existing evidence is limited to agronomic and phytochemical characterization, documenting its curcuminoid content. Health benefit claims must therefore be extrapolated cautiously from broader Curcuma longa research, which itself varies widely in methodology and standardization.

### What are the curcuminoids found in Cherimoya Turmeric?

Like all Curcuma longa varieties, Cherimoya Turmeric contains three primary curcuminoids: curcumin (typically 70–75% of total curcuminoids), demethoxycurcumin (15–20%), and bisdemethoxycurcumin (roughly 3–5%). The Cherimoya cultivar's distinction is its total curcuminoid yield of up to 5.02% by dry weight. Each curcuminoid exhibits slightly different antioxidant potency and metabolic behavior, though curcumin remains the most extensively researched compound.

### How was Cherimoya Turmeric traditionally used?

Cherimoya Turmeric, as a cultivar of Curcuma longa, shares the traditional culinary and preservative applications common to turmeric in Indian and Southeast Asian cuisines, where it has been used for thousands of years as a spice, food colorant, and natural preservative. Its antimicrobial properties, attributed to curcuminoids and essential oils such as turmerone, contributed to its role in food preservation. Ayurvedic and traditional medicine systems used Curcuma longa preparations for digestive complaints and wound care, though these uses were not specific to the Cherimoya cultivar.

### Is Cherimoya Turmeric safe to take as a supplement?

Because no clinical safety data exist specifically for Cherimoya Turmeric supplements, safety assessments are based on the general Curcuma longa evidence base. Curcuminoid supplements are generally considered safe at doses up to 8 g/day in short-term studies, with gastrointestinal discomfort being the most common adverse effect at higher doses. Individuals taking anticoagulants like warfarin, immunosuppressants like tacrolimus, or CYP3A4-metabolized drugs should consult a healthcare provider before use due to potential pharmacokinetic interactions.

### What is the curcuminoid content range in Cherimoya Turmeric compared to standard turmeric varieties?

Cherimoya Turmeric high-yielding genotypes can contain up to 5.02% curcuminoids, which represents the documented upper range for this cultivar variant. Standard turmeric varieties typically contain 3–5% curcuminoids, so Cherimoya Turmeric falls within or slightly above the typical spectrum depending on growing conditions and processing methods. The specific curcuminoid composition varies by harvest and storage conditions, making standardized extracts more consistent than raw powder for supplementation purposes.

### Does Cherimoya Turmeric have antimicrobial properties like other turmeric varieties?

Cherimoya Turmeric contains essential oils such as beta-cymene that have demonstrated antimicrobial properties in laboratory settings. However, these laboratory findings have not been translated into clinical human studies or validated health claims. Traditional culinary use in Indian and Southeast Asian cuisines reflects historical recognition of preservative qualities, but modern supplement efficacy for antimicrobial purposes remains unproven in clinical settings.

### Can Cherimoya Turmeric be obtained from food sources, or is supplementation necessary?

Cherimoya Turmeric is used traditionally as a culinary spice and preservative in Indian and Southeast Asian cuisines, meaning it can be obtained through food sources in these regions. However, availability outside traditional markets is limited, and the curcuminoid content in culinary amounts is generally lower than concentrated supplement doses. For individuals seeking standardized curcuminoid levels, supplementation provides a more consistent and concentrated source than typical dietary use.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*